[Remote] Senior Medical Science Liaison (Sr. MSL) – Oncology, Midwest at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Experience as a Medical Science Liaison (MSL)
Oncology therapeutic area expertise
Ability to identify disease and product-related medical needs
Ability to develop and maintain relationships with KOLs and HCPs
Strong scientific communication and presentation skills
Experience with clinical development, clinical operations, and medical affairs
Ability to translate scientific information into patient care
Extensive travel capability

Responsibilities

Serve as the primary medical resource for the external community
Facilitate peer-to-peer discussions with KOLs and HCPs
Engage in scientific exchange to ensure patient access to clinical trial compounds and marketed products
Provide clinical and scientific advisory support to KOLs and HCPs
Work closely with clinical development, clinical operations, and medical affairs teams
Execute the therapeutic product development process
Translate insights, academic information, and congress data
Play a strategic role in preparing for the launch and commercialization of RayzeBio products
Cultivate and maintain relationships with academic researchers, oncology research centers, and healthcare organizations
Attend conferences, talks, and present scientific product information

Skills

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free